PRMT5 and Miyoshi myopathy: Using the PRMT5 inhibitor EPZ015938, we show PRMT5 inhibition to decrease MM cell growth rate, cell count, and increase apoptosis both in HMCLs and in primary human MM samples depicting different of the known molecular defects.